Literature DB >> 15760431

The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents.

S Brown1, S G B Amyes.   

Abstract

Carbapenem resistance associated with class D beta-lactamases is an increasing problem in Acinetobacter baumannii. Most enzymes of this class reported so far belong to two subgroups, 1 and 2; however, a novel class D carbapenemase (OXA-51) has been reported recently which shares 56% and < 63% amino-acid identity with subgroups 1 and 2, respectively, and which belongs to a third subgroup. This study describes a further seven novel subgroup 3 beta-lactamases in carbapenem-resistant A. baumannii isolates from four continents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760431     DOI: 10.1111/j.1469-0691.2005.01096.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  26 in total

1.  Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.

Authors:  Ji Hoon Baang; Peter Axelrod; Brooke K Decker; Andrea M Hujer; Georgia Dash; Allan R Truant; Robert A Bonomo; Thomas Fekete
Journal:  Am J Infect Control       Date:  2011-08-11       Impact factor: 2.918

2.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.

Authors:  Tatsuya Tada; Shovita Shrestha; Kayo Shimada; Hiroshi Ohara; Jeevan B Sherchand; Bharat M Pokhrel; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

5.  Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.

Authors:  Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.

Authors:  Joshua M Mitchell; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

7.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.

Authors:  Bartolome Moya; Isabel M Barcelo; Sachin Bhagwat; Mahesh Patel; German Bou; Krisztina M Papp-Wallace; Robert A Bonomo; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

9.  Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.

Authors:  Elena Santillana; Alejandro Beceiro; Germán Bou; Antonio Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

10.  Distribution of allelic variants of the chromosomal gene bla OXA-114-like in Achromobacter xylosoxidans clinical isolates.

Authors:  German Matías Traglia; Marisa Almuzara; Andrea Karina Merkier; Mariana Papalia; Laura Galanternik; Marcela Radice; Carlos Vay; Daniela Centrón; María Soledad Ramírez
Journal:  Curr Microbiol       Date:  2013-06-15       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.